Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Debt Ratio (2024 - 2026)

Updated

Revium Rx's (RVRC) Debt Ratio came in at 0.00 for Q2 2026.

Analysis

Revium Rx (RVRC) Debt Ratio (2024 - 2026) Analysis & Trends

  • In prior years, Revium Rx's Debt Ratio was 0.00 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,170.64 Bn 1,139.22 Bn 19.71 Bn 0.39
2 Johnson & Johnson 640.54 Bn 559.06 Bn 17.26 Bn 0.24
3 AbbVie 501.78 Bn 474.89 Bn 12.70 Bn 0.52
4 Merck 374.95 Bn 329.32 Bn 12.21 Bn 0.42
5 Novartis Ag 302.43 Bn 266.42 Bn 11.24 Bn 0.08
6 Astrazeneca 268.31 Bn 241.99 Bn 12.86 Bn 0.28
7 Amgen 242.70 Bn 198.10 Bn 7.24 Bn 0.60
8 Gilead Sciences 193.64 Bn 167.84 Bn 6.22 Bn 0.53
9 Pfizer 172.34 Bn 118.98 Bn 10.94 Bn 0.31
10 Revium Rx 86.84 Mn 86.00 Mn - 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Dec 31, 2025 0.00
Dec 31, 2024 0.00
API Access

Revium Rx Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=RVRC&period=max&api_key=YOUR_API_KEY